Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Midazolam for Symptom Control in Advanced Cancer
NCT01687751Phase 2Withdrawn
- Sponsor
- Fraser Health
- Start
- Nov 2012
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in pain, delirium, Dyspnea, nausea ((none)), sponsored by Fraser Health. Planned start Nov 2012; status: withdrawn.
02
Drugs
dexmedetomidine
03
Conditions
paindeliriumDyspneanausea ((none))
Beyond the preview
Go deeper on NCT01687751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01687751.